COHR

Coherent, Inc.

70
Fundamentals72/ 100
Valuation44/ 100
Upside potential88/ 100
Risk potential19/ 100

COHR has the edge over CRWV overall, supported by stronger fundamentals and stronger modeled upside.

CRWV

CoreWeave, Inc. Class A Common Stock

52
Fundamentals43/ 100
Valuation50/ 100
Upside potential65/ 100
Risk potential42/ 100

CRWV offers stronger valuation, but that advantage does not outweigh its weaker overall profile.

COHR Fundamentals

MetricStatus
Strong
Strong
Weak
Healthy

COHR's revenue, profitability and balance sheet are currently healthy, but its cash flow is weak.

CRWV Fundamentals

MetricStatus
Strong
Under pressure
Weak
Strong

CRWV's revenue and balance sheet are currently strong, but its profitability and cash flow are under pressure.

COHR PE Valuation

CHEAPFAIREXPENSIVE87x174x261x348x
CHEAPFAIREXPENSIVE87x174x261x348x
LevelPEPriceVs current
Forward20x$232—
Cheap27x$130-44%
Fair34x$165-29%
Current48x$232—
Expensive184x$886+282%

Historical ranges are pointers, not guarantees.

COHR's PE is in its fair range at 48x. If earnings grow as analysts expect, today's price would be 20x next year's earnings, in its cheap range.

CRWV PE Valuation

CRWV has no meaningful PE right now: it lost money over the past year.

COHR Forward outlook

MetricOutlook
Strongly improving
Strong growth
Strong growth
Strongly improving
Moderate
Moderate

Analysts expect strong earnings and revenue growth for COHR, with profitability improving.

CRWV Forward outlook

MetricOutlook
--
Losses shrinking
Strong growth
Strongly improving
Moderate
Low

Analysts expect CRWV's losses to shrink, with revenue growing. However, they disagree widely on these estimates.

COHR Risk to reward

ScenarioChangePrice
Upside+138%$551.66
Downside-19%$187.45

Calculated from the latest close: $232.08 on Nov 12.

COHR has a better modeled risk to reward balance than CRWV, with more potential upside and less potential downside.

CRWV Risk to reward

ScenarioChangePrice
Upside+79%$101.48
Downside-42%$32.77

Calculated from the latest close: $56.60 on Nov 12.

CRWV trails COHR on modeled risk to reward, with less potential upside and more potential downside.

COHR Earnings Per Share

Q4 2023: $-2.82Q1 2024: $-2.87Q2 2024: $-1.84Q3 2024: $-1.23Q4 2024: $-0.41Q1 2025: $-0.23Q2 2025: $-0.52Q3 2025: $0.71Q4 2025: $1.03Q1 2026: $2.11Q2 2026: $4.12Q3 2026: $4.83Forward: $11.69
Q4 2023: $-2.82Q1 2024: $-2.87Q2 2024: $-1.84Q3 2024: $-1.23Q4 2024: $-0.41Q1 2025: $-0.23Q2 2025: $-0.52Q3 2025: $0.71Q4 2025: $1.03Q1 2026: $2.11Q2 2026: $4.12Q3 2026: $4.83Forward: $11.69
QuarterTTM EPSYoY
Forward$11.69+142%
Q3 2026$4.83+580%
Q2 2026$4.12+$4.64
Q1 2026$2.11+$2.34
Q4 2025$1.03+$1.44
Q3 2025$0.71+$1.94
Q2 2025-$0.52+$1.32
Q1 2025-$0.23+$2.64
Q4 2024-$0.41+$2.41

COHR has the edge over CRWV on earnings quality, reporting a profit while its opponent remains loss making.

CRWV Earnings Per Share

Q3 2024: $-2.42Q4 2024: $-2.17Q1 2025: $-3.34Q2 2025: $-3.10Q3 2025: $-2.48Q4 2025: $-2.81Q1 2026: $-2.72Q2 2026: $-3.26Q3 2026: $-4.31
Q3 2024: $-2.42Q4 2024: $-2.17Q1 2025: $-3.34Q2 2025: $-3.10Q3 2025: $-2.48Q4 2025: $-2.81Q1 2026: $-2.72Q2 2026: $-3.26Q3 2026: $-4.31
QuarterTTM EPSYoY
Q3 2026-$4.31-$1.83
Q2 2026-$3.26-$0.16
Q1 2026-$2.72+$0.62
Q4 2025-$2.81-$0.64
Q3 2025-$2.48-$0.06

CRWV lost $4.31 per share over the past year, a bigger loss than the year before.

COHR Quarterly Revenue

Q4 2023: $1.1BQ1 2024: $1.2BQ2 2024: $1.3BQ3 2024: $1.3BQ4 2024: $1.4BQ1 2025: $1.5BQ2 2025: $1.5BQ3 2025: $1.6BQ4 2025: $1.7BQ1 2026: $1.8BQ2 2026: $2BQ3 2026: $2.4B
Q4 2023: $1.1BQ1 2024: $1.2BQ2 2024: $1.3BQ3 2024: $1.3BQ4 2024: $1.4BQ1 2025: $1.5BQ2 2025: $1.5BQ3 2025: $1.6BQ4 2025: $1.7BQ1 2026: $1.8BQ2 2026: $2BQ3 2026: $2.4B
QuarterRevenueYoY
Q3 2026$2.4B+50%
Q2 2026$2B+34%
Q1 2026$1.8B+21%
Q4 2025$1.7B+17%
Q3 2025$1.6B+17%
Q2 2025$1.5B+16%
Q1 2025$1.5B+24%
Q4 2024$1.4B+27%

COHR's revenue has grown year over year for 10 quarters in a row: $2.4B last quarter, up 50% from the same quarter a year ago.

CRWV Quarterly Revenue

Q4 2023: $116MQ1 2024: $189MQ2 2024: $395MQ3 2024: $584MQ4 2024: $747MQ1 2025: $982MQ2 2025: $1.2BQ3 2025: $1.4BQ4 2025: $1.6BQ1 2026: $2.1BQ2 2026: $2.6BQ3 2026: $3.7B
Q4 2023: $116MQ1 2024: $189MQ2 2024: $395MQ3 2024: $584MQ4 2024: $747MQ1 2025: $982MQ2 2025: $1.2BQ3 2025: $1.4BQ4 2025: $1.6BQ1 2026: $2.1BQ2 2026: $2.6BQ3 2026: $3.7B
QuarterRevenueYoY
Q3 2026$3.7B+168%
Q2 2026$2.6B+112%
Q1 2026$2.1B+112%
Q4 2025$1.6B+110%
Q3 2025$1.4B+134%
Q2 2025$1.2B+207%
Q1 2025$981.6M+420%
Q4 2024$747.4M+544%

CRWV has the edge over COHR on sales, with stronger typical year-over-year growth.

COHR Free Cash Flow

Q4 2023: −$24MQ1 2024: $24MQ2 2024: $62MQ3 2024: $61MQ4 2024: $82MQ1 2025: $51MQ2 2025: −$1MQ3 2025: −$58MQ4 2025: −$96MQ1 2026: −$383MQ2 2026: −$486MQ3 2026: −$868M
Q4 2023: −$24MQ1 2024: $24MQ2 2024: $62MQ3 2024: $61MQ4 2024: $82MQ1 2025: $51MQ2 2025: −$1MQ3 2025: −$58MQ4 2025: −$96MQ1 2026: −$383MQ2 2026: −$486MQ3 2026: −$868M
QuarterFree cash flowYoY
Q3 2026-$868.2M-$810.2M
Q2 2026-$486.2M-$485.2M
Q1 2026-$383.5M-850%
Q4 2025-$95.7M-217%
Q3 2025-$58M-195%
Q2 2025-$1.1M-102%
Q1 2025$51.1M+111%
Q4 2024$81.7M+$106M

COHR has the edge over CRWV on cash flow, with more consistent year-over-year improvement.

CRWV Free Cash Flow

Q4 2023: −$1.1BQ1 2024: $297MQ2 2024: −$2.4BQ3 2024: −$574MQ4 2024: −$3.3BQ1 2025: −$1.3BQ2 2025: −$2.7BQ3 2025: −$700MQ4 2025: −$2.5BQ1 2026: −$4.7BQ2 2026: −$5.7BQ3 2026: −$7.5B
Q4 2023: −$1.1BQ1 2024: $297MQ2 2024: −$2.4BQ3 2024: −$574MQ4 2024: −$3.3BQ1 2025: −$1.3BQ2 2025: −$2.7BQ3 2025: −$700MQ4 2025: −$2.5BQ1 2026: −$4.7BQ2 2026: −$5.7BQ3 2026: −$7.5B
QuarterFree cash flowYoY
Q3 2026-$7.5B-$6.8B
Q2 2026-$5.7B-$3B
Q1 2026-$4.7B-$3.4B
Q4 2025-$2.5B+$810.3M
Q3 2025-$699.8M-$125.8M
Q2 2025-$2.7B-$339.3M
Q1 2025-$1.3B-553%
Q4 2024-$3.3B-$2.2B

CRWV has burned cash in almost every quarter: −$20.4B over the past year, against −$8.1B the year before.

COHR Total Shares

Q4 2023: 152MQ1 2024: 152MQ2 2024: 152MQ3 2024: 154MQ4 2024: 160MQ1 2025: 155MQ2 2025: 155MQ3 2025: 191MQ4 2025: 193MQ1 2026: 196MQ2 2026: 195MQ3 2026: 202M
Q4 2023: 152MQ1 2024: 152MQ2 2024: 152MQ3 2024: 154MQ4 2024: 160MQ1 2025: 155MQ2 2025: 155MQ3 2025: 191MQ4 2025: 193MQ1 2026: 196MQ2 2026: 195MQ3 2026: 202M
PeriodChange %Net change
Quarterly+3.4%+6.6M shares
1 year+5.9%+11.3M shares
3 years+34%+51.7M shares
5 years+74%+86.2M shares
Available history+122%+111M shares

COHR has the edge over CRWV on shareholder dilution, with a more favorable share count trend.

CRWV Total Shares

Q4 2023: 404MQ1 2024: 404MQ2 2024: 404MQ3 2024: 214MQ4 2024: 239MQ1 2025: 249MQ2 2025: 487MQ3 2025: 498MQ4 2025: 436MQ1 2026: 527MQ2 2026: 551MQ3 2026: 559M
Q4 2023: 404MQ1 2024: 404MQ2 2024: 404MQ3 2024: 214MQ4 2024: 239MQ1 2025: 249MQ2 2025: 487MQ3 2025: 498MQ4 2025: 436MQ1 2026: 527MQ2 2026: 551MQ3 2026: 559M
PeriodChange %Net change
Quarterly+1.5%+8M shares
1 year+12%+61.1M shares

CRWV has 559M diluted shares, up 12% from a year ago.

COHR Net Leverage

Q4 2023: 6.0xQ1 2024: 6.6xQ2 2024: 4.8xQ3 2024: 4.8xQ4 2024: 4.6xQ1 2025: 5.1xQ2 2025: 8.1xQ3 2025: 4.1xQ4 2025: 3.5xQ1 2026: 1.7xQ2 2026: 1.5xQ3 2026: 1.7x
Q4 2023: 6.0xQ1 2024: 6.6xQ2 2024: 4.8xQ3 2024: 4.8xQ4 2024: 4.6xQ1 2025: 5.1xQ2 2025: 8.1xQ3 2025: 4.1xQ4 2025: 3.5xQ1 2026: 1.7xQ2 2026: 1.5xQ3 2026: 1.7x
QuarterNet LeverageStatus
Q3 20261.7xHealthy
Q2 20261.5xHealthy
Q1 20261.7xHealthy
Q4 20253.5xElevated
Q3 20254.1xHigh
Q2 20258.1xHigh
Q1 20255.1xHigh
Q4 20244.6xHigh

COHR's net debt is about 1.7 years of its operating earnings (EBITDA), down from 4.1 years a year ago.

CRWV Net Leverage

Q4 2024: 19.3xQ1 2025: 8.4xQ2 2025: 6.5xQ3 2025: 5.6xQ4 2025: 7.6xQ1 2026: 7.6xQ2 2026: -1.5xQ3 2026: -0.8x
Q4 2024: 19.3xQ1 2025: 8.4xQ2 2025: 6.5xQ3 2025: 5.6xQ4 2025: 7.6xQ1 2026: 7.6xQ2 2026: -1.5xQ3 2026: -0.8x
QuarterNet LeverageStatus
Q3 2026-0.8xNet Cash
Q2 2026-1.5xNet Cash
Q1 20267.6xHigh
Q4 20257.6xHigh
Q3 20255.6xHigh
Q2 20256.5xHigh
Q1 20258.4xHigh
Q4 202419.3xHigh

CRWV has the edge over COHR on leverage, with a lower net debt burden relative to earnings.

COHR Weekly Momentum

MetricValueStatus
RSI43.6Neutral
Stochastic16.5Oversold

COHR's weekly RSI is 44 (neutral) and its Stochastic is 16 (oversold).

CRWV Weekly Momentum

MetricValueStatus
RSI39.7Neutral
Stochastic11.3Oversold

CRWV's weekly RSI is 40 (neutral) and its Stochastic is 11 (oversold).

COHR PE vs Technology Sector

MetricCOHRSector medianRelative
PE48x28x72% above
PE %583523 pts above

COHR is trading at 48x earnings, a 72% premium to the Technology sector's median of 28x.

CRWV PE vs Technology Sector

CRWV has no meaningful PE right now: it lost money over the past year.

COHR Weekly Moving Averages

Moving averageMA priceRelative
8 week MA$252.98.2% below
20 week MA$284.118% below
50 week MA$277.716% below
100 week MA$185.925% above
200 week MA$120.692% above

COHR has stronger trend alignment. COHR is above 2 of 5 weekly averages versus CRWV above 0 of 3.

CRWV Weekly Moving Averages

Moving averageMA priceRelative
8 week MA$66.615% below
20 week MA$77.427% below
50 week MA$87.435% below

CRWV is in a downtrend: it's below all three of its weekly moving averages, and 35% below its 50-week average.

COHR Yearly ROI

YearStart priceEnd priceROI
2020$33.5$77.8+132%
2021$77.8$68.0-13%
2022$68.0$33.1-51%
2023$33.1$43.5+32%
2024$43.5$97.0+123%
2025$97.0$191.7+98%
2026 YTD$191.7$232.1+21%

COHR has the edge over CRWV on returns for 2026, with the stronger performance.

CRWV Yearly ROI

YearStart priceEnd priceROI
2025$40.0$76.4+91%
2026 YTD$76.4$56.6-26%

CRWV has finished every year since 2025 higher, and it's down 26% so far in 2026.

Give your agent the market.

Get API key